Gsa Capital Partners LLP Applied Molecular Transport Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.32 - $0.68 $102,808 - $218,468	-321,277 Reduced 71.94%	125,334 $40,000
Q4 2022 Feb 13, 2023	BUY	$0.35 - $1.26 $93,413 - $336,290	266,897 Added 148.51%	446,611 $188,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $180,920 - $503,992	161,536 Added 888.63%	179,714 $175,000
Q2 2022 Aug 09, 2022	SELL	$2.76 - $7.65 $145,990 - $404,646	-52,895 Reduced 74.42%	18,178 $53,000
Q1 2022 May 11, 2022	BUY	$5.63 - $13.88 $38,959 - $96,049	6,920 Added 10.79%	71,073 $534,000
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $199,124 - $392,078	15,051 Added 30.65%	64,153 $897,000
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $1.27 Million - $2.29 Million	49,102 New	49,102 $1.27 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.